Citadel Advisors - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V957. A total of 4 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2016$444,000
-3.7%
14,900
-5.1%
0.00%
-100.0%
Q1 2016$461,000
-9.6%
15,700
+141.5%
0.00%0.0%
Q4 2015$510,000
-37.9%
6,500
-40.4%
0.00%0.0%
Q3 2015$821,000
-41.9%
10,900
-9.9%
0.00%0.0%
Q2 2015$1,413,000
-63.1%
12,100
-25.3%
0.00%
-75.0%
Q1 2015$3,825,000
+52.0%
16,200
+21.8%
0.00%
+100.0%
Q4 2014$2,517,000
-50.7%
13,300
-37.9%
0.00%
-60.0%
Q3 2014$5,105,000
+1070.9%
21,400
+224.2%
0.01%
Q2 2014$436,000
-55.9%
6,600
-30.5%
0.00%
-100.0%
Q1 2014$989,0009,5000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 416$7,874,0000.25%
SIMPLEX TRADING, LLC 89$392,0000.05%
GROUP ONE TRADING, L.P. 900$170,0000.00%
Citadel Advisors 13,300$2,517,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders